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The anorexic voice (AV) is defined as a critical internal dialogue which has been implicated in the 
development and maintenance of anorexia nervosa (AN). Systematic research to explore this further 
requires a valid and reliable measurement tool. This study aimed to develop and assess the validity of 
the Experience of an Anorexic VoicE Questionnaire (EAVE-Q). EAVE-Q items were developed and 
checked for face and content validity through cognitive interviews with seven individuals diagnosed 
with AN. Participants with a diagnosis of AN (N = 148) completed the EAVE-Q, sociodemographic 
questions and measures of mood and quality of life to assess internal consistency and construct 
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validity.  Forty-nine participants completed the EAVE-Q twice more to assess test-retest reliability. 
The EAVE-Q had good face and content validity and good acceptability. Principal axis factoring 
resulted in an 18-item scale organised into five domains with high internal consistency (α = .70 to α 
= .85). Domains correlated significantly with eating disorder symptoms, psychological distress and 
quality of life. The EAVE-Q did not discriminate between participants on the basis of body mass index. 
Test-retest reliability was moderate. Although the factor structure of the EAVE-Q requires replication 
in other AN samples, the EAVE-Q is the first measure of a critical internal dialogue in AN. It is hoped 
that it will aid future research to increase understanding of AN and the continued development of 
person-centred treatments.  
 
Practitioner Points:  
• Research has indicated that people with a diagnosis of anorexia nervosa report that they 
experience an internal ‘voice’ that gives the eating disorder an identity and drives its severity.  
• The relationship between the anorexic voice and the self appears to be crucial in 
understanding its role in increasing eating disorder severity. There is a lack of an evidence-
based measure of the relationship between the self and the ‘voice’.   
• The EAVE is an evidence-based measure that looks at the relationship between the self and 





Qualitative research in Anorexia Nervosa (AN) has identified the experience of an ‘anorexic voice’ (AV) 
(Higbed & Fox, 2010; Tierney & Fox, 2010), hypothesised to be a key psychological component which 
may contribute to the development and maintenance of AN. The AV is defined as “a critical-internal 
dialogue (i.e. a second or third commentary which is ‘heard’), orientated around shape, weight, 
eating and their implications for self-worth” (Pugh, 2016, p.1). The AV has been hypothesised to drive 
weight-related attitudes and motivate individuals to engage in unhealthy weight control practices 
(Hendricks, 2003; Shelley, 1997); quantitative data have supported this idea (Pugh et al., 2017; 
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2018). Although conceptualised as a ‘voice’, the AV has been differentiated from auditory verbal 
hallucinations (AVHs) because it is described simultaneously as a separate entity and a part of one’s 
own inner speech (Higbed & Fox, 2010; Williams & Reid, 2012). Comparison of females with and 
without an eating disorder (ED) found that the former reported more internal dialogue about eating, 
weight and self-worth (Scott et al., 2014). In a study by Noordenbos and colleagues (2104), 94.5% 
of participants with an ED experienced a critical inner voice compared to 29.3% of healthy controls; 
the former also heard this voice significantly more frequently.  
Researchers have drawn on aspects of dialogical self-theory (Hermans, Kempen & Van Loon, 
1992) to understand the AV, suggesting it represents an internal self-critical position that attempts to 
dominate the more rational self (Hendricks, 2003; Williams & Reid, 2012; Williams, King & Fox, 
2015). Furthermore, it has been associated with attachment theory, described as an intrapersonal, 
significant relationship that can affect someone’s self-image (Mantailla et al., 2018a; 2018b).  
The AV is said to change in nature and intensity over time (Tierney & Fox, 2010), a process 
reflected in findings from a meta-synthesis by Duncan et al. (2015). Initially, it appears to provide 
comfort and security but then becomes more sinister and powerful as AN progresses, consuming 
thoughts, driving behaviour and triggering negative emotions when rules and expectations are 
ignored (Tierney & Fox, 2010; Tierney & Fox, 2011; Williams & Reid, 2012). This change to negative 
appraisals of the AV, and its conceptualisation as a “voice”, has been indicated as a severity marker, 
switching from controlled dieting to an ED (Williams & Reid, 2012; Williams et al., 2015). This is 
accompanied by realisations of physical emaciation, loss of control and contemplation of help seeking 
(Williams & Reid, 2012). However, the AV might be a barrier to accessing help because despite its 
negative consequences, its positive attributes may make it difficult to relinquish (Tierney & Fox, 2010; 
Williams et al., 2015). Attempts to encourage someone to break their bond with the AV may 
engender separation distress (Mantilla et al., 2018a).  
It has been hypothesised that externalising anorexic thoughts as a voice may be helpful for 
recovery, and that therapeutic techniques facilitating acceptance of difficult internal experiences and 
the taking of more dominant, positive internal positions should be explored (Higbed & Fox, 2010; 
Williams et al., 2015; Williams & Reid, 2012). A study by Pugh and Waller (2016), using a scale 
developed for AVHs, found the perceived power of the AV was positively associated with ED 
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symptoms. However, the authors acknowledged this study potentially measured AN thoughts more 
generally rather than the AV specifically (Pugh & Waller, 2016). This research points to the potential 
importance of targeting the AV in psychological treatment, but also highlights the need for a measure 
developed specifically to capture the AV. To date, Dolhanty and Greenberg (2009) is the only case-
study where the AV has been the focus of treatment, using emotion-focussed therapy (EFT) to 
decrease its harshness with moderate improvement in depression and ED symptoms.      
 
Criticisms of the AV concept 
It has been suggested the AV may be just another way of conceptualising thoughts related to AN 
(Fairburn, Shafran & Cooper, 1999). However, there is evidence the AV can be reliably distinguished 
from other inner dialogues such as self-criticism (Noordenbos, Aliakbari, & Campbell, 2014), 
indicating it may be a separate cognitive phenomenon (Pugh, 2016). The AV has also been criticised 
as being a purely social construct, emerging through research and therapeutic approaches rather 
than individual experience directly (Maisel, Epston & Borden, 2004). Yet qualitative research reports 
that individuals identify with the experience of an AV prior to contact with services (Williams et al., 
2015). Finally, some have warned against the externalisation of AN as a voice, fearing it could lead to 
diminished responsibility over behaviour and recovery (Wright & Hacking, 2012) or give greater 
power to anorexic features such as the sense of being controlled (Higbed & Fox, 2010). However, 
qualitative descriptions unequivocally characterise the AV as both a separate entity and an integral 
part of the self (e.g. Williams et al., 2015), and research advocates not to ‘get rid’ of the AV, but 
rather to change the relationship between the AV and the individual (Higbed & Fox, 2010).  
 
Objectives 
There is little systematic research exploring the AV and this is difficult to progress without a valid and 
reliable measurement tool. To our knowledge, no existing scale adequately captures AV concepts or 
experiences. As such, this study aimed to develop, test and refine the Experience of an Anorexic 
VoicE Questionnaire (EAVE-Q). The development of this measure was informed by the findings of 
qualitative interview data from nine individuals with AN (Evans, 2014) alongside a review of the 
existing qualitative AV literature (Higbed & Fox, 2010; Tierney & Fox, 2010; Tierney & Fox, 2011; 
6 
 
Williams & Reid, 2012; Williams et al., 2015). This identified five recurring themes underlying the AV 
experience: identity and externalising (i.e. conceptualising the AV as part of the self and a separate 
entity); positive functions (e.g. promotion of perceived control); negative consequences (e.g. social 
withdrawal); power and dominance (e.g. the sense of the AV taking over the self); and the AV as a 
barrier to recovery (e.g. promoting secrecy). The research aims were to assess: 1) the face and 
content validity of the EAVE-Q through cognitive interviews; 2) the dimensions of the EAVE-Q using 
exploratory factor analysis (EFA); 3) the internal consistency of the EAVE-Q domains with a clinical 
sample; 4) construct validity by evaluating if EAVE-Q domains were significantly associated with 
severity markers of AN, specifically Body Mass Index (BMI), eating disorder symptoms, mood and 
quality of life (QoL); 5) test-retest reliability of the total scale and its subscales. 
Based on the literature (e.g. Tierney & Fox, 2010) and assuming EFA would confirm the 
above mentioned dimensional structure of the EAVE-Q, it was predicted that any domains related to 
‘Positive functions of the AV’ and ‘Externalising the AV’ would be associated with decreased distress 
and increased QoL, given these are linked to coping and recovery. Conversely, we predicted that 
domains related to ‘negative consequences of the AV’, ‘power and dominance of the AV’, and ‘the AV 




Ethical approval was received from the North West NHS Research Ethics Committee.   
 
 
Stage 1: Scale Development 
Method 
Item generation 
Item generation was guided by the five hypothesised AV domains, with a minimum of five marker 
variables per dimension to provide a scale with a stable solution (Tabachnick & Fidell, 2013). Items 
were developed by the authors using quotations and themes from original interview transcripts in the 
study by Evans (2014) and other relevant articles (Shelley, 1997; Hendricks, 2003; Higbed & Fox, 
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2010; Tierney & Fox, 2010; Williams & Reid, 2012; Noordenbos, Aliakbari & Campbell, 2014; 
Williams, King & Fox, 2015). The initial scale contained 74 items about AV experiences over the 
previous week and used a five point Likert scale. 
 
Face validity, content validity and scale refinement 
Cognitive interviews (Willis & Artino, 2013) were carried out with seven women with a diagnosis of 
AN (see Table 1) to confirm items had content and face validity and to improve the design of the 
measure. A standardised interview protocol was developed using existing guidelines (Willis, 2005) and 
included questions which probed key cognitive processes. The scale was also reviewed at a therapy 
group by four individuals with a diagnosis of AN receiving inpatient treatment at a specialist ED unit. 
 
[Table 1 here] 
Results 
Based on consensus between participants, seven items were re-phrased and one was deleted where 
a consensus on clear wording could not be reached. The remaining items had high face validity. 
Content validity was also good, although four additional items were added to capture perceived 
missing aspects of the AV. The final scale had 77 items (see Table 2).  
 
[Table 2 here] 
 
Stage 2: Psychometric analysis 
Sample 
A recruitment target of 150 participants was set, which was above the absolute minimum criteria of 
100 required for Factor Analysis (FA; Kline, 1994) and would allow for the reliable detection of 
correlations > .22 with an alpha level of .5 and power at .80 for other planned analyses. The Kaiser-
Meyer-Olkin (KMO) measure of sampling adequacy (Kaiser, 1974) was also calculated, with a KMO of 
>.5 indicating adequate sample size for FA (Hutcheson & Sofroniou, 1999). Participants aged ≥ 16 
years were eligible because mid-adolescence is a key time for onset of AN (Fairburn & Harrison, 
2003). Participants were required to self-report a diagnosis of AN and to obtain a global mean score 
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> 3.5 on the Eating Disorders Examination Questionnaire (EDE-Q, Fairburn & Beglin, 1994), which is 
within 0.5 of a standard deviation (SD) from the mean global EDE-Q score established in a previous 
study with a large AN help-seeking sample (Aardoom, Dingemans, Slof Op’t Landt & Van Furth, 
2012). BMI was not used to determine eligibility as weight restoration alone is not sufficient for 
recovery from AN (Fichter, Quaflieg & Hedlund, 2006; Accurso, Ciao, Fitzsimmons-Craft, Lock & Le 
Grange, 2014). Figure 1 shows the recruitment and screening process. The final sample included 148 
participants. The overall KMO for the EAVE-Q was .85, with KMOs for individual items ranging from 
.69 to .92. Forty-nine participants completed the EAVE-Q at two further time points to provide an 
estimate of test-retest reliability.  
 
[Figure 1 here] 
 
Measures 
Clinical history information and measures of ED symptom severity, psychological distress and QoL 
were used for diagnostic purposes and to assess construct validity of the EAVE-Q.  
 
Background questionnaire  
This collected relevant sociodemographic data and screened for eligibility. Information regarding 
predictors of AN severity were recorded, including age of onset, length of illness, BMI and total time 
in treatment (Schneider, Fisher, Weinerman & Lesser, 2002; Treasure & Russell, 2011). 
 
The Eating Disorder Examination Questionnaire 6.0 (EDE-Q; Fairburn & Beglin, 1994) 
A 33-item scale to assess disordered eating over a 28-day period and likely AN caseness. Higher 
scores indicated increased symptom severity. The EDE-Q discriminates accurately between those with 
and without an ED diagnosis (Aardoom et al., 2012; Berg, Peterson, Frazier & Crow, 2012). 
Cronbach’s α (Cronbach, 1951) for EDE-Q global scores in the current sample was .81, with a mean 
EDE-Q score of 4.86 (SD = 0.69), which is similar to mean scores reported for AN groups in other 
studies where mean global EDE-Q scores >3.60 have been found (Aardoom et al., 2012; Brewin, 




The Structured Clinical Interview for Diagnosis, ED Module I (SCID-DSM-5 Research Version; APA 
2013)  
A structured interview used to validate AN diagnosis in a sub-group of respondents following 
completion of the questionnaires (see ‘Procedure’). A BMI of <18.5 was used to indicate ‘significantly 
low weight’ based on current guidance (National Obesity Observatory, UK, 2009). A proportion of 
interviews (20%) were rated independently by a second researcher to assess reliability. Inter-rater 
agreement for AN diagnosis was 100%.  
 
Depression Anxiety Stress Scale (DASS-21; Lovibond & Lovibond, 1995; Appendix 11) 
 A 21-item scale measuring distress over the past week on three subscales (depression, anxiety and 
stress), with higher scores indicating more severe symptoms. Internal consistency for the DASS-21 
here was high (total scale: α = .92; subscales: α = .80 to α = .92).   
 
World Health Organisation Quality of Life Assessment (WHOQOL-BREF; Skevington, Lotfy & O-
Connell, 2004; Appendix 12) 
A 26-item measure assessing QoL over the previous four weeks in four domains: physical health, 
psychological health, social relationships and environmental. Higher scores indicate better QoL. 
Internal consistency here was acceptable to good, with α = .89 for the total scale, and α =.65 to .82 
for individual domains.   
 
Procedure 
This was a cross-sectional, questionnaire-based study, with an optional telephone interview using the 
SCID-DSM-5 to confirm diagnosis at a later point. Participants were recruited through flyers 
distributed to public and voluntary ED services, charities and service user groups across the UK, 
Australia, Canada, and America. The study was also advertised on social media and online ED forums. 
Participants visited the study website or requested information via post (n = 2), and provided 
informed consent in writing or online. To confirm eligibility the background questionnaire was 
completed, followed by the EDE-Q. Eligible participants were directed to the main study page or sent 
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the study measures via post according to preference. The EAVE-Q was completed first; and the 
remaining measures were presented in random order. Participants provided optional consent for the 
SCID-DSM-5 interview or permission to contact a qualified clinician to validate AN diagnosis. All SCID 
interviews (n = 64) were completed by the first author and audio-recorded with participant consent. 
To assess test-retest reliability, participants were asked to complete the online questionnaires twice 
more, seven days apart. Up to three reminders were sent.    
 
 Data analysis 
Exploratory factor analysis 
Redundant items were identified and deleted if: a) one response category was used by >50% of 
respondents; b) two response categories were used by <10% of respondents; or c) the neutral 
response category was used by >30% of the sample (Benson & Vincent, 1980; McSharry, Bishop, 
Moss-Morris, Holt & Kendrick, 2015). Remaining items with inter-item correlations (IICs) >.30 and 
<.90 (Tabachnick & Fidell, 2013) were included for FA. Bartlett’s test of sphericity was calculated, 
with a significant result indicating FA was likely to be meaningful. Exploratory FA was used to analyse 
and consolidate variables within the scale. Principal axis factoring (PAF) was used for factor extraction 
as items were moderately skewed (Fabrigar, Wegener, MacCallum & Strahan, 1999). Parallel analysis 
(PA; Horn, 1965) determined factor retention as this is the most accurate method with samples <200 
(Velicer & Jackson, 1990). Only eigenvalues larger than those occurring by chance were retained. 
Promax rotation aided interpretation as correlations between factors were predicted. Items with no 
factor loadings >.40 were removed (Stevens, 2002) and items cross-loading on two or more factors 
>.32 were deleted to improve interpretability of the measures’ dimensions (Tabachnick & Fidell, 
2013). A minimum criterion of three variables per factor was specified (Costello & Osborne, 2005). 
Individual subscales were assessed and items with corrected item-total correlations (ITCs) <.30 were 
removed (Hair, Anderson, & Tatham, 1995; Tabachnick & Fidell, 2013). PAF was repeated following 
the removal of any variables to assess changes in the factor structure. Very high between-factor 
correlations were considered suggestive of overlapping dimensions better explained by a single factor 






Correlations between total and subscale EAVE-Q scores and clinical outcomes (DASS-21, WHOQOL-
BREF, EDE-Q and BMI) were calculated using Spearmans Rho (rs) due to non-parametric data. The 
proportion of variance accounted for (R2) was calculated for significant correlations to aid 
interpretation of importance.  
 
Sensitivity analyses  
This study included a proportion of participants who were below the clinical threshold for AN as 
eligibility was not defined by BMI or formal diagnosis. To assess how representative the sample were 
of a clinical population, participants with a validated diagnosis (n = 50) were compared to participants 
with self-report data and BMI < 18.5 (n = 54). Differences between groups for continuous variables 
(age, BMI, DASS-21 scores, WHOQOL-BREF scores, EDE-Q scores) were compared using the 
independent t-test. Differences in categorical variables (gender, current treatment and length of 
treatment) were explored using Chi Square analyses. The ability of the EAVE-Q to discriminate 
between those above and below clinical threshold for AN was assessed within the full sample using 
the t-test to compare EAVE-Q scores when participants were separated into a ‘clinical’ group 
(validated diagnosis of AN or BMI < 18.5; n = 104) and a ‘sub-threshold’ group (BMI >18.5; n = 44).  
 
Test-retest reliability 
The intraclass correlation (ICC) between sub-scale scores and total EAVE-Q scores collected at Time 1 
and Time 2 was calculated. A two-way mixed effects model with single measurement and absolute 
agreement was selected (Koo & Li, 2016). ICCs <0.5 were considered poor, 0.5 - 0.75 moderate, 








[Table 3 here] 
 
Exploratory Factor analysis 
After removing 44 redundant items, all remaining items had IICs >.30 and <.90 and were included 
for FA. Bartlett’s test of sphericity was highly significant (p <.0001), indicating FA was appropriate. 
Items retained for FA used the entire response scale, indicating good scale to sample targeting. PA 
indicated seven initial factors occurring above chance (see Figure 2). Items with no factor loadings 
>.40 were removed (n = 7). Two of the initial seven factors had only two items loading >.40 and 
were deleted (n = 4 items). Four items cross-loading >.32 were also deleted. In total eight PAF 
analyses were required to find the most interpretable factor structure with the fewest items and 
adequate internal consistency. PAF analyses were run with seven, six, five and four factors selected 
for extraction with the remaining 18 items. The five-factor solution provided the best fit for the data 
(see Table 4), with 54.83% of the total variance explained and average communalities of .55.  
 
 [Table 4 here] 
[Figure 2 here] 
 
Interpreting factors 
Although the five-factor model was consistent with the proposed theoretical model of the EAVE-Q, the 
factors extracted were not identical to those predicted. Factors 1 and 2 encompassed hypothesised 
benefits of the AV, but were clearly distinguishable dimensions. Factor 1, labelled ‘Benefits of 
adhering to the AV’, related to the positive consequences of obeying the AV’s demands and was 
linked to perceived control and positive emotions. Factor 2, labelled ‘The compassionate AV’, 
represented a more supportive function, linked to feelings of being comforted and understood by the 
AV.  As predicted, Factor 3 encompassed items depicting the AV as a barrier to recovery. However, 
items loading onto this factor were specifically linked to mistrust and distancing the self from others, 
and so was re-labelled ‘Turning away from others’. Factor 4 was as hypothesised and retained the 
label ‘Externalising the AV’, capturing the extent to which individuals identified the AV as part of, or 
external to, themselves. Similarly, Factor 5 had items loading onto it which were proposed to 
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underpin a powerful and dominant domain and so retained the label ‘Dominated by the AV’. The 
hypothesised ‘Negative consequences of engaging with the AV’ was not found, with these aspects of 
the AV potentially subsumed within other factors.  
 
Reliability  
Cronbach’s α for the full scale was α = .83. All subscales had good internal consistency (see Table 5), 
with ITCs >.30 and α ranging from α = .70 to α = .85.  
 
[Table 5 here] 
 
Construct validity 
Moderate correlations between factors were predicted and suggested EAVE-Q domains measured a 
shared, higher order construct (the AV). No two factors were so highly correlated that they were 
likely to have been better explained by a single factor (see Table 6). In general, factors had small to 
moderate correlations, as would be expected in a multidimensional scale. ‘Benefits of adhering to the 
AV’ and ‘The compassionate AV’ domains were largely correlated, which is consistent with the 
hypothesis that these are both positive functions of the AV. However, items did not cross-load on to 
the other dimension >.32 and so were retained as separate factors. ‘The compassionate AV’ 
dimension correlated moderately with ‘Turning away from others’, indicating the experience of a 
supportive AV was associated with people withdrawing from external support. ‘Externalising the AV’ 
correlated to some extent with ‘The compassionate AV’ and the ‘Dominated by the AV’ domains. 
‘Externalising the AV’ and ‘Benefits of adherence’ were uncorrelated, suggesting the extent to which 
individuals see the AV as part of themselves or as a separate entity does not relate to positive 
appraisals of the AV experience.  
 
[Table 6 here] 
 
Associations between EAVE-Q domains and clinical outcomes 
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Significant correlations between EAVE-Q domains and other clinical outcomes ranged from small to 
moderate (see Table 7). The ‘Dominated by the AV’, ‘Turning away from others’ and ‘The 
compassionate AV’ subscales were all moderately and positively correlated with ED symptoms. 
‘Benefits of adherence’ was also positively correlated with EDE-Q scores, although to a lesser extent. 
No correlations accounted for more than 50% variance in EDE-Q scores. All EAVE-Q domains were 
significantly positively associated with the EDE-Q Restraint, Shape Concern and Weight Concern 
subscales. Eating concern was also significantly associated with higher scores on the ‘Turning away 
from others’ and ‘Dominated by the AV’ domains. Small but significant correlations were found 
between EDE-Q vomiting and compulsive exercise behaviours and the ‘Dominated by the AV’ 
subscale.  
Age of onset was negatively correlated with the ‘Turning away from others’ subscale, whilst 
‘The compassionate AV’ subscale was negatively associated with years since first onset. There was no 
difference in EAVE-Q scores on any domain between individuals identified as AN-R and AN-BP using 
the SCID (see Table 8).  
 ‘Turning away from others’ was positively and moderately associated with DASS-21 scores. All 
domains on the DASS-21 had small, but significant, positive correlations with scores on the 
‘Dominated by the AV’ dimension, with correlations approaching a moderate association for the DASS-
21 stress subscale. ‘The compassionate AV’ domain correlated positively with anxiety scores on the 
DASS-21 only, whilst ‘Benefits of adherence’ did not correlate well with any subscales on the DASS-
21.  
 ‘Turning away from others’ was significantly and negatively associated with all domains of the 
WHOQOL-BREF, being most associated with scores on the psychological domain which includes 
questions about self-acceptance and the meaning and enjoyment of life. All WHOQOL-BREF domains 
correlated negatively with ‘Dominated by the AV’ scores, most notably the psychological domain and 
the social domain, which records satisfaction with relationships and support. In contrast, the ‘Benefits 
of adherence’ scale had small, positive associations with WHOQOL-BREF physical, psychological and 
environmental domains. Only the environmental domain achieved significance, which includes 
questions about access to health services, financial security and opportunities for leisure activities. 
‘The compassionate AV’ had small negative correlations with psychological and social domains on the 
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WHOQOL-BREF, but these were not approaching significance. BMI was not significantly associated 
with any of the EAVE-Q domains. The ‘Externalising the AV’ scale was not correlated with any clinical 
outcomes.  
  
[Table 7 here] 
[Table 8 here] 
 
Sensitivity analyses 
Sixty-four participants completed the SCID and five more had diagnosis verified by their health 
professional. Of those, 50 participants met full criteria for AN; 36 for restricting type and 14 for binge-
purge type. Fourteen people were sub-threshold for AN on the SCID due to having BMI >18.5 or 
failing to meet full criteria for fear of weight gain or disturbance of weight or shape. Participants with 
a validated diagnosis of AN (n = 50, mean age = 32.14 years) were significantly older than those 
who were underweight with self-report data only (n = 54, mean age = 25.35 years; t(102) =3.14, p 
= .002; MD = 6.79, 95% CI = 2.49 - 11.08). However, groups did not differ significantly on any other 
outcomes, suggesting similar severity of AN and psychological distress. This indicates that participants 
with self-report data and BMI <18.5 were generally representative of a clinical AN sample. There was 
no significant difference in EAVE-Q scores for the ‘clinical group’ (participants with a validated 
diagnosis or BMI <18.5; n = 104) and those who were ‘sub-threshold’ for AN (BMI >18.5; n = 44) 
(see Table 9). Therefore, whilst linked to ED symptoms and psychological distress, endorsement of 
AV experiences was not associated with lower weight. Finally, one outlier (>3 times the interquartile 
range) was identified based on mean EAVE-Q scores.  All analyses were completed with and without 
this person’s data; no difference in the factor structure of the EAVE-Q was found, which appeared 
robust within this sample. 
 
[Table 9 here] 
 
Test-retest reliability  
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Average time between Time 1 and Time 2 EAVE-Q completion was 29 days (see Table 10).  ICCs for 
the total scale score and individual EAVE-Q domains were all within the ‘moderate’ range.  
 
[Table 10 here] 
 
Discussion 
This paper describes the development of the first scale measuring the AV. Exploratory FA resulted in 
18 items organised into five domains to form the EAVE-Q. As predicted, domains pertaining to 
‘Externalising the AV’ and ‘Dominated by the AV’ were identified, capturing the duality and 
powerlessness associated with experiences of the AV reported in the literature (e.g. Tierney & Fox, 
2010). The hypothesised domain of ‘The AV as a barrier to recovery’ was not found, but instead a 
more specific dimension of ‘Turning away from others’ was elicited and underpinned by beliefs about 
trust and self-worth in relationships. The hypothesised dimension of the AV having a positive function 
was identified but was better conceptualised as two separate domains. ‘The compassionate AV’ 
encapsulated a supportive function of the AV, whilst ‘Benefits of adhering to the AV’ encompassed 
positive consequences of engagement. The hypothesised negative consequences of the AV domain 
had unexpected nuances and was differentiated as negative internal consequences in the ‘Dominated 
by the AV’ domain, and negative social consequences in the ‘Turning away from others’ dimension. 
Internal consistency for the EAVE-Q was high for this sample, who predominantly met clinical 
threshold for AN, indicating that the scale was reliably measuring the AV construct.   
 Test-retest reliability was moderate and construct validity was good. Except for the 
‘Externalising the AV’ subscale, all dimensions were significantly and positively correlated with EDE-Q 
scores, suggesting that the AV is an important clinical feature of AN. Other researchers have 
highlighted that feeling overpowered and controlled by the AV, and submitting to this, is associated 
with greater eating pathology (Mantilla et al., 2018b; Pugh & Waller, 2017). Likewise, positive beliefs 
about the AV have been associated with disordered eating attitudes (Pugh et al., 2018), in line with 
our findings on the domain ‘Benefits of adhering to the AV’.  
No correlations accounted for more than 50% variance in EDE-Q scores, indicating that the 
AV is not just another way of conceptualising cognitive and behavioural symptoms of AN (Hinken, 
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Tracey & Enz, 1997). There were significant correlations between EAVE-Q scores and measures of 
eating restraint, vomiting, compulsive exercise, shape concern and weight concern, supporting 
assertions that the AV is linked to weight-related attitudes and weight management behaviour 
(Higbed & Fox, 2010; Tierney & Fox, 2010) although causality cannot be assumed due to the cross-
sectional nature of this study.  
As predicted, there were significant positive correlations between EAVE-Q domains, 
psychological distress and AN severity markers. The ‘Turning away from others’ and ‘Dominated by 
the AV’ domains were moderately associated with depression, anxiety and stress, and reduced QoL. 
The largest effects were found for associations with psychological and social WHOQOL-BREF domains. 
This is logical, as the social domain measures satisfaction with relationships, which would not be 
expected for people endorsing the ‘Turning away from others’ subscale. The psychological domain 
assesses self-acceptance and satisfaction with weight and shape, which would also not be predicted 
for people endorsing the ‘Dominated by the AV’ scale, as perceptions of being powerless to resist the 
AV have been associated with feelings of failure, guilt and shame (Tierney & Fox, 2011). ‘Benefits of 
adherence’ had small positive associations with three of the four WHOQOL-BREF subscales, although 
only associations with the environmental subscale reached significance. This may be due to this 
WHOQOL subscale including questions about satisfaction with access to health services, as 66% of 
the sample was receiving current treatment. Age of onset was moderately and negatively correlated 
with the ‘Turning away from others’ subscale, with younger age of onset associated with individuals 
endorsing their AV prevented them from trusting others and feeling worthy of help. ‘The 
compassionate AV’ subscale was also negatively associated with years since first onset, suggesting 
that those who had lived with AN symptoms the longest were less likely to endorse the 
compassionate aspects of their AV.   
There were no significant associations between ‘Benefits of adherence’ and DASS-21 scores, 
or ‘The compassionate AV’ and QoL scores. This is surprising, as the literature would suggest that the 
positive functions of the AV are the avoidance of painful emotions and the protection of self-esteem 
(e.g. Williams & Reid, 2012), and so negative relationships between these domains and distress, and 
positive associations with QoL were expected. There was also a small positive correlation between the 
DASS-21 anxiety subscale and ‘The compassionate AV’ subscale, and a small negative correlation 
18 
 
between ‘The compassionate AV’ domain and QoL, which was counter-intuitive. The size of these 
associations indicates future research with a larger sample is required to assess if they are robust. If 
so, this could be reflective of the tension between the AV’s positive and negative aspects, and the 
potential insecure attachments many individuals have with their EDs (Mantilla et al., 2018b). It is 
possible that as anxiety increases, endorsement of the AV as supportive and comforting also 
increases, as people turn to a trusted and relied upon coping strategy (Tierney & Fox, 2010).  
 The literature suggests that externalising the AV could be a key part of recovery (Higbed & 
Fox, 2010); therefore, positive associations with QoL and negative associations with psychological 
distress and ED symptoms were predicted. No such associations were found, raising questions about 
the clinical utility of this domain. Limited sample size and the non-parametric distribution of items 
within the scale may mean some items lacked variability and more subtle associations were missed. 
Whether associated with clinical outcomes or not, perhaps a more relevant question is the utility of 
this domain in understanding the experience of the AV. As ‘Externalising the AV’ was a robust 
dimension in FA and in the qualitative literature underpinning this study, it was retained for further 
analysis in future research.  
 
Limitations 
The non-parametric distribution of individual EAVE-Q items means that results of FA are restricted to 
the study sample (Field, 2005). The sample was predominantly White British (70%) and female 
(97%), meaning results may not be generalisable to individuals with AN from other cultures or males. 
The EAVE-Q did not distinguish between clinical and sub-threshold participants based on BMI, which 
is perhaps not surprising given that only participants with clinically relevant scores on the EDE-Q were 
included, and that psychological recovery does not co-occur with weight restoration alone (Fichter et 
al., 2006; Le Grange et al., 2013). Others have also noted no association between characteristics of 
the AV and BMI (Pugh et al., 2018). However, the accuracy of self-reported weight is a potential 
confound, as research regarding accuracy of weight reporting is contentious for clinical and recovered 
AN samples (McCabe, McFarlane, Polivy & Olmsted, 1999; Wolfe, Kelly-Weeder, Malcolm & McKenery, 
2013). Participants also self-reported diagnosis of AN, although attempts were made to check this via 
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SCID interview or confirmation with health professionals, and sensitivity analyses suggested no 
significant clinical differences between those with or without a validated diagnosis of AN. 
 
Clinical Implications 
Other authors have highlighted how severity of eating pathology can be associated with appraisal of 
the AV as strong and powerful (Pugh & Waller, 2017; Pugh et al., 2018). Our study provides further 
evidence for the clinical importance of the AV in AN. Higher EAVE-Q scores were associated with 
negative ED attitudes, increased psychological distress, and decreased QoL. The EAVE-Q could be 
used to introduce discussions about the AV within clinical settings, promoting shared understandings 
and formulations between clients and professionals. The EAVE-Q could also be used to assess the 
ability of existing interventions to target the AV.  
 
Implications for Future Research 
This study provides a refined scale ready for validation in other AN samples. Further research is 
required to determine: a) if the ‘Externalising the AV’ domain is a key facet of the AV, and to clarify 
patterns of associations with clinical outcomes and their meaning, and b) to what extent the AV, as 
assessed by the EAVE-Q, mediates clinical outcomes, such as ED symptoms, QoL and use of services. 
Considering the lack of recent studies exploring novel treatment strategies in AN (Lipsman, Woodside 
& Lozano, 2014), the development and assessment of psychological approaches targeting the AV is a 
worthwhile pursuit. A potential starting point is EFT (Greenberg & Johnson, 1988), as there is 
evidence that EFT techniques addressing the harshness of the AV can reduce depression and ED 
symptoms (Dolhanty & Greenberg, 2009). The EAVE-Q could be used to measure if reductions in AV 
endorsement mediate these outcomes. Narrative therapy has also been proposed as a means of 
enabling people to explore more adaptive attachment relationships outside of their ED (Mantilla et al., 
2018a); again, the EAVE-Q could be used to examine the validity of this claim. Furthermore, 
compassion-focused approaches (Goss & Allan, 2014) could enable individuals to be more kind and 
forgiving to their own perceived failings, counteracting negative internal encounters shaped by how 





When considering new directions for future research and treatment in AN, it is important to consider 
the priorities and perspectives of those experiencing this ED. The EAVE-Q is the first stage in the 
development of a reliable and valid measure of the AV based on experiences of individuals with a 
diagnosis of AN. The EAVE-Q provides a tool to aid the continuing development of patient-centred 
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Table 1. Stage 1 cognitive interview sample characteristics 
Variable n = 7 
Age (years)  
   Mean 26 
   Range 18 – 54 
Ethnicity:  
   White British 7 
25 
 
Current treatment for AN 7 
BMI < 18.5 7 
Place of interview  
   Participant’s home 2 
   Community location    3 
   Inpatient ward 2 
26 
 
Table 2. EAVE-Q Items prior to EFA (n = 77) 
Identity & Externalising  
(n = 7) 
Negative consequences of engaging 
with the AV (n = 13) 
The AV as a barrier to recovery  
(n = 14) 
Power & dominance of the AV 
(n = 24) 
Positive functions of the AV 
(n = 19) 
* I experience my AV as thoughts that are 
not my own 
* My AV misleads me  * My AV tells me that it’s the only thing I 
should rely on 
* My AV is a voice in my head which 
influences how I think and feel 
* My AV is supportive 
* My AV is like hearing someone else’s 
thoughts and feelings 
* My AV makes me feel weak * I want to get rid of my AV * My AV is a feeling inside which influences 
what I can and can’t do 
* My AV is comforting 
* My AV is part of who I am * My AV is a negative part of my life * My AV makes the things I do to lose weight 
seem OK 
* My AV is always there * My AV is a friend to me 
* I see my AV as separate from my own 
identity 
* My AV is harmful to me * I can control my AV * My AV tells me I should be punished * My AV understands me when other people 
don’t 
* My AV is always the same gender * My AV makes me act like someone I don’t 
want to be 
* My AV makes me think other people just 
want me to get fat 
* My AV is so loud it’s hard to hear any other 
thoughts 
* My AV helps me to cope when things are 
difficult 
* My AV reminds me of someone I know * My AV makes me feel isolated * My AV tells me not to trust other people * My AV gets louder when I’m feeling 
stressed or down 
* My AV is a positive part of my life 
* I see my AV as something that shouldn’t 
be there 
* I feel angry with my AV * My AV motivates me to want to lose weight * I believe everything my AV says * My AV makes me feel in control 
 * My AV makes me feel angry or frustrated 
with myself 
* My AV makes me secretive and hide things 
from other people 
* My AV becomes louder when I ignore it * My AV gives me a positive sense of routine 
and order in my life 
 * My AV makes me feel angry or frustrated 
with other people 
* I can ignore my AV if I really want to * My AV gets louder when I eat something it 
says I shouldn’t 
* Doing what my AV says makes me feel 
satisfied 
 * My AV makes me think that life isn’t worth 
living 
* My AV makes me think I don’t deserve 
other people’s help 
* My AV bullies me * Doing what my AV says makes me feel 
happy 
 * My AV distresses me * My AV makes me believe I don’t deserve 
food 
* My AV controls me * My AV gives me a sense of purpose   
27 
 
Identity & Externalising  
(n = 7) 
Negative consequences of engaging 
with the AV (n = 13) 
The AV as a barrier to recovery  
(n = 14) 
Power & dominance of the AV 
(n = 24) 
Positive functions of the AV 
(n = 19) 
 * My AV makes it hard for me to maintain 
relationships with others 
* My AV advises me to get help * My AV criticises me * My AV gives me a sense of achievement 
 * When I hear my AV negative images come 
into my mind 
* I need to get rid of my AV to feel like I 
have completely recovered 
* My AV is powerful * My AV makes me a better person 
  * Treatment should help me manage my AV * My AV takes over me * My AV makes me feel less alone 
   * My AV is strong * My AV makes me feel safe 
   * My AV gets stronger when I gain weight * My AV makes me feel confident 
   * My AV gets stronger when I lose weight * I feel lonely when my AV is not there  
   * My AV makes me feel anxious or panicky 
when I go against it 
* When I hear my AV comforting images 
come into my mind 
   * My AV makes me feel guilty when I go 
against it 
* My AV helps me block out painful thoughts 
and feelings 
   * My AV gives me rules and regulations I 
have to follow 
 
   * My AV makes me feel ashamed when I go 
against it 
 
   * It doesn’t matter what I do, my AV always 
wins 
 
   * Not doing what my AV tells me makes me 
feel exhausted 
 
   * I feel like I’m battling against my AV  
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Table 3. Stage 2 sample characteristics (n = 148) 
Variable    n / value 
Age Mean 27.74 years 
 Range 16 – 63 

























Education GCSE or equivalent 
A-level or equivalent 






Age at first AN symptoms Mean 
Range 
15.09 years 
5 – 39 years 




11 – 49 
n = 1 












Length of AN treatment 
 
Never treated 
< 1 year 
1 – 2 years 
3 – 4 years 
5 – 6 years 









Current BMI Mean (SD) 
Range 
17.61 (2.44) 
13.17 – 25.53 
EDE-Q: Mean (SD) 
  
Global score 4.86 (0.69) 

































Item 1 2 3 4 5 
My AV makes me feel in control .837 -.063 -.082 .096 -.106 
My AV gives me a positive sense of routine and order in my life .754 -.011 .033 .021 -.051 
Doing what AV says makes me feel happy .630 .029 .055 -.116 .044 
Doing what AV says makes me feel satisfied .626 .057 -.010 -.047 .135 
My AV makes me feel confident .499 .111 -.032 -.024 -.042 
My AV is supportive -.091 .826 -.005 .058 -.123 
My AV is comforting .094 .788 -.137 .020 .047 
My AV is a friend to me .098 .759 .079 -.004 -.035 
My AV understands me when other people don’t .114 .548 .140 -.058 .104 
My AV makes me think other people just want me to get fat .094 -.127 .899 -.007 -.137 
My AV tells me not to trust other people -.053 .071 .861 .017 .033 
My AV makes me think I don’t deserve other people’s help -.123 .098 .455 .021 .137 
I experience my AV as thoughts that are not my own .075 -.073 .011 .922 .023 
I see my AV as separate from my own identity -.134 .113 -.071 .672 -.099 
My AV is like hearing someone else’s thoughts and feelings .024 .025 .121 .576 .132 
It doesn’t matter what I do my AV always wins .047 -.062 -.003 -.029 .795 
I can ignore my AV if I really want to (reversed) -.167 -.013 .002 -.022 .639 
My AV controls me .102 -.001 -.031 .089 .606 
NB Extraction method: Principal axis factoring; Rotation: Promax with Kaiser normalisation. Items in bold type and underlined are items loading onto each factor >.40 
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Table 5. Cronbach’s alpha reliability coefficients of the EAVE-Q scales derived from FA 
Dimension Number of items α ITC range 
1. Benefits of adhering to the AV 5 0.81 0.48 – 0.66 
2. The compassionate AV 4 0.85 0.62 – 0.77 
3. Turning away from others 3 0.78 0.47 – 0.73 
4. Externalising the AV 3 0.77 0.54 – 0.72 






















Table 6. EAVE-Q factor correlation matrix 
 
Benefits of adherence Compassionate AV Turning away from others Externalising the AV Dominated by the AV  Total 
Scorea 
Benefits of adherence 
 
1.000 .568** .277** .095 .291**  .731** 
Compassionate AV 
 
.568** 1.000 .389** .243* .209*  .795** 
Turning away from others 
 
.277** .389** 1.000 .201* .297**  .582** 
Externalising the AV 
 
.095 .243* .201* 1.000 .121  .451** 
Dominated by the AV 
 
.291** .209* .297** .121 1.000  .400** 
* Significant at the p <.01 level; ** Significant at the p <.001 level 
a Correlation between subscales and EAVE-Q total score
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Age of onset (n = 148) -0.86 (.301) .123 (.135) -.106 (.199) -.313 (<.001*) -0.99 (.231) 0.11 (.891) 
Years since 1st onset  
(n = 148) -1.09 (.188) -0.55 (.507) -.164 (.046*) -.079 (.341) -.017 (.842) .095 (.249) 
EDE-Q Global 
Mean (n = 148) 
.419  (<.001*) .234  (<.01*) .312  (<.001*) .442  (<.001*) -.007  (.935) .482  (<.001*) 
EDE-Q Restraint .339 (<.001*) .240 (<.01*) .198 (.016*) .322 (<.001*) -.029 (.727) .493 (<.001*) 
EDE-Q Eating concern .159 (.054) -.015 (.852) .112 (.176) .284 (<.001*) .022 (.792) .314 (<.001*) 
EDE-AQ Shape concern .401 (<.001*) .231 (<.01*) .319 (<.001*) .410 (<.001*) -.022 (.791) .350 (<.001*) 
EDE-Q Weight concern .397 (<.001*) .237 (<.01*) .359 (<.001*) .360 (<.001*) -.042 (.608) .350 (<.001*) 
EDE-Q Binge eating .074 (.369) -0.64 (.442) .134 (.106) .140 (.089) .028 (.740) .039 (.637) 
EDE-Q Vomiting .079 (.342) -.010 (.906) .076 (.360) .091 (.269) -.041 (.623) .171 (.038*) 
EDE-Q Laxatives -.009 (.912) -.070 (.399) -.014 (.869) .125 (.131) -.101 (.222) .109 (.187) 
EDE-Q Compulsive 
exercise 
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(n = 141): 
            
Total score   
 
.246  (.003*) -.040  (.638) .150  (.077) .472  (<.001*) .031 (.718) .268  (.001*) 
Depression   
 
.142  (.094) -.099  (.243) .074  (.383) .396  (<.001*) -.010  (.904) .215  (.010*) 
Anxiety  
 
.275  (.001*) .023  (.782) .187  (.027*) 
 
.472  (<.001*) .061  (.472) .177   (.036*) 
Stress  .222  (.008*) .004  (.966) .141  (.153) .347  (<.001*) .032  (.706) .294  (<.001*) 
WHOQOL-BREF  
Domains (n = 142): 
 
            
Physical  
 
-.100  (.238) .154  (.068) -.017  (.839) -.320  (<.001*) -.022  (.796) -.295  (<.001*) 
Psychological  -.148  (.079) .117  (.166) -.115  (.173) -.377  
 
(<.001*) .038  (.653) -.266  (.001*) 
Social  
 
-.177  (.035*) -.037  (.665) -.117  (.167) -.227  
 
(<.01*) .064  (.452) -.305  (<.001*) 
Environmental  
 
-.053  (.535) .196  (.019*) .003  (.976) -.302  (<.001*) .007  (.931) -.180  (.032*) 
NB As some variables were not normally distributed, all correlations reported are for Spearman’s correlation coefficient (rs) for ease of interpretation, as a 
sensitivity analysis showed no significant difference in the size and direction of correlations or significance values when using Pearson’s r to calculate the 





Table 8. Comparison of scores between AN-R and AN-BP as assessed using the SCID 
EAVE-Q Domain:  
Mean (SD) 
AN-R   
(n = 36) 
AN-BP 
(n = 14) 
Test statistic  
(df) 
p value MD 95% CI 
Total EAVE-Q score 
Benefits of adherence 
The compassionate AV 
Turning away from others 
Externalising the AV 































-0.41 – 0.41 
-0.71 - 0.50 
-0.99 - 0.48 
-0.92 - 0.42 
-0.15 – 1.26 
-0.33 - 0.72 
  
 
Table 9. Comparison of EAVE-Q scores between a ‘clinical’ and ‘subthreshold’ group 
EAVE-Q Domain:  
Mean (SD) 
Clinical   
(n = 104) 
Subthreshold 
(n = 44) 
Test statistic  
(df) 
p value MD 95% CI 
Total EAVE-Q score 
Benefits of adherence 
The compassionate AV 
Turning away from others 
Externalising the AV 













t (146) = 0.32 
t (146) = 0.64 
t (146) = 1.44 
t (146) = -0.19 
t (146) = -0.56 













-0.19 – 0.27 
-0.23 – 0.44 
-0.11 – 0.68 
-0.39 – 0.32 
-0.49 – 0.28 















Table 10. Assessment of test-retest reliability using Intraclass Correlation Coefficient 
(n = 49)  
 
 
Completed Time 1 and 2, Mean delay: 29 days (range 6 - 76), 
n = 49 
Item  Cronbach’s Alpha ICC* 95% Confidence Interval p value 
Total EAVE-Q score .85 .74 .58 - .85 <.001 
Benefits of adherence .81 .68 .49 - .80 <.001 
The compassionate AV .78 .64 .44 - .78 <.001 
Turning away from 
others 
.87 .76 .62 - .86 <.001 
Externalising the AV .82 .70 .52 - .82 <.001 
Dominated by the AV .82 .68 .50 - .81 <.001 
*ICC values using two way mixed effects model, single measurement, absolute agreement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
